Page 84 - BH-2-3

Brain & Heart Lipids in ALS: Bad and beneficial

sclerosis. Am J Clin Nutr. 2001;74(3):328-334. Irwin JJ, Shoichet BK. Relating protein pharmacology by
ligand chemistry. Nat Biotech. 2007;25(2):197-206.
doi: 10.1093/ajcn/74.3.328
doi: 10.1038/nbt1284
7. Funalot B, Desport JC, Sturtz F, Camu W, Couratier P. High
metabolic level in patients with familial amyotrophic lateral 18. Daina A, Michielin O, Zoete V. SwissADME: A free web
sclerosis. Amyotroph Lateral Scler. 2009;10(2):113-117. tool to evaluate pharmacokinetics, drug-likeness and
medicinal chemistry friendliness of small molecules. Sci
doi: 10.1080/17482960802295192
Rep. 2017;7:42717.
8. Kwong KCN, Mehta AR, Nedergaard M, Chandran S.
Defining novel functions for cerebrospinal fluid in ALS doi: 10.1038/srep42717
pathophysiology. Acta Neuropathol Commun. 2020;8:140. 19. Morris SM. Recent advances in arginine metabolism:
Roles and regulation of the arginases. Br J Pharmacol.
doi: 10.1186/s40478-020-01018-0
2009;157:922-930.
9. Wong JK, Roselle AK, Shue TM, et al. Apolipoprotein
B-100-mediated motor neuron degeneration in doi: 10.1111/j.1476-5381.2009.00278.x
sporadic amyotrophic lateral sclerosis. Brain Commun. 20. Trott O, Olson AJ. AutoDock Vina: Improving the speed
2022;44:fcac207. and accuracy of docking with a new scoring function,
efficient optimization, and multithreading. J Comput Chem.
doi: 10.1093/braincomms/fcac207
2010;31(2):455-461.
10. Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy doi: 10.1002/jcc.21334
metabolism in amyotrophic lateral sclerosis. Lancet Neurol.
2011;10(1):75-82. 21. Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock
Vina 1.2.0: New docking methods, expanded force field, and
doi: 10.1016/S1474-4422(10)70224-6
python bindings. J Chem Inf Model. 2021;61(8):3891-3898.
11. D’Amico E, Grosso G, Nieves JW, Zanghì A, Factor-Litvak P,
Mitsumoto H. Metabolic abnormalities, dietary risk factors doi: 10.1021/acs.jcim.1c00203
and nutritional management in amyotrophic lateral 22. Fatoki T, Chukwuejim S, Ibraheem O, et al. Harmine
sclerosis. Nutrients. 2021;13(7):2273. and 7,8-dihydroxyflavone synergistically suitable for
amyotrophic lateral sclerosis management: An in silico
doi: 10.3390/nu13072273
study. Res Results Pharmacol. 2022;8(3):49-61.
12. Dodge JC, Treleaven CM, Pacheco J, et al. Glycosphingolipids doi: 10.3897/rrpharmacology.8.83332
are modulators of disease pathogenesis in amyotrophic lateral
sclerosis. Proc Natl Acad Sci U S A. 2015;112(26):8100-8105. 23. Fatoki TH, Faleye BC, Nwagwe OR, et al. Friedelin Could
moderately modulate human carbonic anhydrases: An in
doi: 10.1073/pnas.1508767112
silico study. Biointerface Res Appl Chem. 2024;14(2):49.
13. Henriques A, Croixmarie V, Priestman DA, et al.
Amyotrophic lateral sclerosis and denervation alter doi: 10.33263/BRIAC142.049
sphingolipids and up-regulate glucosylceramide synthase. 24. Tao A, Huang Y, Shinohara Y, Caylor ML, Pashikanti S,
Hum Mol Genet. 2015;24(25):7390-73405. Xu D. ezCADD: A rapid 2D/3D visualization-enabled web
modeling environment for democratizing computer-aided
doi: 10.1093/hmg/ddv439
drug design. J Chem Inf Model. 2019;59(1):18-24.
14. Blasco H, Veyrat-Durebex C, Bocca C, et al. Lipidomics doi: 10.1021/acs.jcim.8b00633
reveals cerebrospinal-fluid signatures of ALS. Sci
Rep. 2017;7:17652. 25. Schrödinger. Schrödinger Release 2018-3. Desmond Molecular
Dynamics System: Maestro Desmond Interoperability Tools.
doi: 10.1038/s41598-017-17389-9
New York: D. E. Shaw Research, Schrödinger; 2018.
15. Chaves-Filho AB, Pinto IFD, Dantas LS, et al. Alterations 26. Ali I, Iqbal MN, Ibrahim M, Haq IU, Alonazi WB, Siddiqi AR.
in lipid metabolism of spinal cord linked to amyotrophic Computational exploration of novel ROCK2 inhibitors for
lateral sclerosis. Sci Rep. 2019;9(1):11642.
cardiovascular disease management; insights from high-
doi: 10.1038/s41598-019-48059-7 throughput virtual screening, molecular docking, DFT and
MD simulation. PLoS One. 2023;18(11):e0294511.
16. Luikinga S, Henriques A, Ngo ST, et al. Profound lipid
dysregulation in mutant TDP-43 mice is ameliorated by the doi: 10.1371/journal.pone.0294511
glucocerebrosidase 2 inhibitor ambroxol. BioRxiv Preprint. 27. Fatoki TH. Effect of pH on structural dynamics of HMG-
2022.
CoA reductase and binding affinity to β-sitosterol. J Biomol
doi: 10.1101/2022.08.30.505901 Struct Dyn. 2023;41(10):4398-4404.
17. Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, doi: 10.1080/07391102.2022.2067240

Volume 2 Issue 3 (2024) 13 doi: 10.36922/bh.2976